Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study

被引:104
|
作者
Falcone, Marco [1 ]
Tiseo, Giusy [1 ]
Giordano, Cesira [2 ]
Leonildi, Alessandro [1 ]
Menichini, Melissa [2 ]
Vecchione, Alessandra [2 ]
Pistello, Mauro [3 ,4 ]
Guarracino, Fabio [5 ]
Ghiadoni, Lorenzo [6 ]
Forfori, Francesco [7 ]
Barnini, Simona [2 ]
Menichetti, Francesco [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Infect Dis Unit, Pisa, Italy
[2] Azienda Osped Univ Pisana, Microbiol Unit, Pisa, Italy
[3] Univ Pisa, Virol Unit, Dept Lab Med, Pisa Univ Hosp, Pisa, Italy
[4] Univ Pisa, Retrovirus Ctr, Dept Translat Res, Pisa, Italy
[5] Azienda Osped Univ Pisana, Dept Anaesthesia & Crit Care Med, Pisa, Italy
[6] Univ Pisa, Dept Clin & Expt Med, Emergency Med Unit, Pisa, Italy
[7] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care Med, Pisa, Italy
关键词
D O I
10.1093/jac/dkaa530
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Bacterial and fungal superinfections may complicate the course of hospitalized patients with COVID-19. Objectives: To identify predictors of superinfections in COVID-19. Methods: Prospective, observational study including patients with COVID-19 consecutively admitted to the University Hospital of Pisa, Italy, between 4 March and 30 April 2020. Clinical data and outcomes were registered. Superinfection was defined as a bacterial or fungal infection that occurred >= 48 h after hospital admission. A multivariate analysis was performed to identify factors independently associated with superinfections. Results: Overall, 315 patients with COVID-19 were hospitalized and 109 episodes of superinfections were documented in 69 (21.9%) patients. The median time from admission to superinfection was 19 days (range 11-29.75). Superinfections were caused by Enterobacterales (44.9%), non-fermenting Gram-negative bacilli (15.6%), Gram-positive bacteria (15.6%) and fungi (5.5%). Polymicrobial infections accounted for 18.3%. Predictors of superinfections were: intestinal colonization by carbapenem-resistant Enterobacterales (OR 16.03, 95% CI 6.5-39.5, P< 0.001); invasive mechanical ventilation (OR 5.6, 95% CI 2.4-13.1, P< 0.001); immunomodulatory agents (tocilizumab/baricitinib) (OR 5.09, 95% CI 2.2-11.8, P< 0.001); C-reactive protein on admission >7 mg/dl (OR 3.59, 95% CI 1.7-7.7, P= 0.001); and previous treatment with piperacillin/tazobactam (OR 2.85, 95% CI 1.1-7.2, P= 0.028). Length of hospital stay was Longer in patients who developed superinfections ompared with those who did not (30 versus 11 days, P< 0.001), while mortality rates were similar (18.8% versus 23.2%, P= 0.445). Conclusions: The risk of bacterial and fungal superinfections in COVID-19 is consistent. Patients who need empiric broad-spectrum antibiotics and immunomodulant drugs should be carefully selected. Infection control rules must be reinforced.
引用
收藏
页码:1078 / 1084
页数:7
相关论文
共 50 条
  • [31] Predicting Pneumonia: A Prospective Observational Study Of The Risk Factors For Hospital-Acquired And Ventilator-Associated Bacterial Pneumonia
    Bergin, S. P.
    Coles, A.
    Farley, J.
    Santiago, J.
    Calvert, S.
    Fowler, V. G.
    Holland, T. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] A novel strategy for predicting critical illness in hospital-acquired COVID-19
    Cho, Woo Hyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (03): : 371 - 372
  • [33] An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs
    Shbaklo, Nour
    Corcione, Silvia
    Vicentini, Costanza
    Giordano, Susanna
    Fiorentino, Denise
    Bianco, Gabriele
    Cattel, Francesco
    Cavallo, Rossana
    Zotti, Carla Maria
    De Rosa, Francesco Giuseppe
    ANTIBIOTICS-BASEL, 2022, 11 (05):
  • [34] Decreased hospital-acquired respiratory infections among older inpatients during the COVID-19 pandemic: a retrospective observational study in a general hospital in China
    Li, Qian
    Zhao, Lihua
    Chen, Jin
    Qu, Shuang
    Niu, Xiaoting
    Zhu, Ruixia
    Hu, Wei
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [35] Reducing Hospital-Acquired Pressure Injuries During the COVID-19 Pandemic
    Wild, Kelly
    Makic, Mary Beth Flynn
    CRITICAL CARE NURSE, 2022, 42 (02) : 82 - 84
  • [36] Predominance of hospital-acquired bloodstream infection in patients with Covid-19 pneumonia
    Engsbro, Anne Line
    Israelsen, Simone Bastrup
    Pedersen, Michael
    Tingsgaard, Sandra
    Lisby, Gorm
    Andersen, Christian O.
    Benfield, Thomas
    INFECTIOUS DISEASES, 2020, 52 (12) : 919 - 922
  • [37] Prevention of hospital-acquired infections: A construct during Covid-19 pandemic
    Mitra, Manasij
    Ghosh, Amrita
    Pal, Ranabir
    Basu, Maitraye
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (09) : 3348 - 3354
  • [38] Hospital-acquired infections in a tertiary hospital in Iran before and during the COVID-19 pandemic
    Abdolreza Mohammadi
    Fatemeh Khatami
    Zohreh Azimbeik
    Alireza Khajavi
    Mehdi Aloosh
    Seyed Mohammad Kazem Aghamir
    Wiener Medizinische Wochenschrift, 2022, 172 : 220 - 226
  • [39] Evaluation of the impact of COVID-19 pandemic on hospital-acquired infections in a tertiary hospital in Malaysia
    Ismaeil, Rehab
    Nahas, Abdul Rahman Fata
    Kamarudin, Norhidayah Binti
    Abubakar, Usman
    Mat-Nor, Mohamad Basri
    Mohamed, Mohamad Haniki Nik
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [40] Hospital-acquired infections in a tertiary hospital in Iran before and during the COVID-19 pandemic
    Mohammadi, Abdolreza
    Khatami, Fatemeh
    Azimbeik, Zohreh
    Khajavi, Alireza
    Aloosh, Mehdi
    Aghamir, Seyed Mohammad Kazem
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (9-10) : 220 - 226